(ME NewsWire)-- Masimo (NASDAQ:MASI) announced today that the Dubai Health Authority (DHA), the government organization that oversees the healthcare systems of Dubai, is augmenting its current inventory of Masimo equipment and technology with the implementation of Masimo Patient SafetyNet™*, a supplemental remote monitoring and clinician notification system, at two hospitals in Dubai. Masimo Patient SafetyNet enables information from bedside monitors, such as Masimo Root® with the Radical-7® or wearable Radius-7® Pulse CO-Oximeter®, to be accessible from a central viewing station. When changes occur in measured values,......

Gulf Inject, a Julphar company - the region’s leading pharmaceutical manufacturer, has announced it has signed a local distribution agreement with Zulekha Healthcare Group.

The business milestone event was"...

(ME NewsWire)-- WIN Consortium (WIN) received the US Food and Drug Administration (FDA)’s approval to start the clinical investigation of a novel therapeutic approach using a combination of three targeted therapies for the first line treatment"...

[ AETOS Wire ] -- Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the performance of Masimo SpHb®, noninvasive, continuous hemoglobin measurement, in trauma patients with low hemoglobin levels.1 In the prospective, observational study, Dr. Gamal and colleagues sought to evaluate SpHb measurements on trauma patients with low hemoglobin levels (below 8 g/dL) because trauma patients are “vulnerable to frequent blood transfusion.” They enrolled 70 adult patients with hemoglobin levels lower than 8 g/dL who were admitted to the emergency department......

Graminex® LLC, producer of Graminex® Flower Pollen Extracts™, receives Health Canada Approval under the Natural and Non-prescription Health Products Directorate (NNHPD) for its PollenAid® and Prostanex® Flower Pollen Extract™ formulations.

Health"...

Adolescents in Lebanon are increasingly seeking the psychedelic properties of a mind-altering drug, Salvia Divinorum, believed to be the most potent naturally occurring hallucinogen. Commonly known as a sacred spiritual plant native of the mountains of Mexico, Salvia has spread on the international"...

(ME NewsWire)-- Masimo (NASDAQ: MASI) announced today that researchers at the Tokyo Women’s Medical University, Department of Anesthesiology, in Japan have published a study investigating the measurement of respiration rate in volunteers. Masimo acoustic respiration rate (Masimo), using the Masimo Radical-7® Pulse CO-Oximeter®, was studied alongside Nellcor plethysmographic respiration rate (Nellcor), using the Nellcor PM1000N.1 Dr. Kitsiripant and colleagues enrolled 50 healthy adult volunteers in the study. Respiration rate, pulse rate, and oxygen saturation (SpO2) values were measured using the two technologies: Nellcor respiration......

The Saudi National Campaign to support Syrian refugees has continued distributing bread to displaced Syrians in Lebanon and northern Syria through its mobile bakeries, the Saudi Press Agency (SPA) said.
In the 196th week of operations inside Syria, the mobile bakeries produced 1.272"...

(ME NewsWire)-- Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue growth of 6.6% led by Takeda's Growth Drivers Underlying Revenue grew +6.6% with growth across all regions (U.S. +13.5%, Japan +1.6%, Europe & Canada +4.6%, Emerging Markets +6.0%). Takeda's Growth Drivers (GI, Oncology, CNS and Emerging Markets) maintained their strong momentum to deliver growth of +14.7%. GI (Gastroenterology) +23.2%, led by continued success of ENTYVIO® and TAKECAB® Oncology +12.2%, driven by NINLARO®,......

• First patient enrolled into VOLTAIRE-X; an interchangeability study designed to assess whether BI 695501 is interchangeable with Humira®1
• First study in the U.S. to investigate an interchangeability designation for an adalimumab biosimilar candidate
• BI 695501 is currently under review by regulatory authorities2

...